TY - JOUR AU - Kokorovic, Andrea AU - So, Alan I. AU - Serag, Hosam AU - French, Christopher AU - Hamilton, Robert J. AU - Izard, Jason P. AU - Nayak, Jasmir G. AU - Pouliot, Fréderic AU - Saad, Fred AU - Shayegan, Bobby AU - Aprikian, Armen AU - Rendon, Ricardo A. PY - 2021/05/31 Y2 - 2024/03/28 TI - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies – Executive summary JF - Canadian Urological Association Journal JA - CUAJ VL - 15 IS - 6 SE - CUA Guideline DO - 10.5489/cuaj.7357 UR - https://cuaj.ca/index.php/journal/article/view/7357 SP - 159-61 AB - <p>Androgen deprivation therapy (ADT) plays an important role in the contemporary management of prostate cancer (PCa) across various stages of the disease. While ADT remains a highly effective treatment for PCa, it is not curative, and its use is associated with significant adverse events that span across various organ systems.</p> ER -